Fibrillation, Atrial Clinical Trial
Official title:
Artificial Intelligence Use for the Detection of Atrial Fibrillation Drivers
pilot clinical study, multicenter, prospective, open, nonrandomized
The hypothesis is that ablation targeting PVI alone for the treatment of persistent AF is less efficient that ablation targeting electrophysiologic areas with spatio-temporal-dispersion with or without PVI ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00244725 -
Odiparcil For The Prevention Of Venous Thromboembolism
|
Phase 2 | |
| Terminated |
NCT00437242 -
Odiparcil QT Definitive Study
|
Phase 1 | |
| Completed |
NCT00402363 -
Evaluation of Efficacy and Safety of Lovaza (Omega-3-Acid Ethyl Esters) in Recurrent, Symptomatic Atrial Fibrillation
|
Phase 3 | |
| Completed |
NCT00240643 -
Use Of SB424323 With Aspirin In Non-Valvular Atrial Fibrillation In Patients At A Low Or Intermediate Risk For Stroke
|
Phase 2 | |
| Completed |
NCT00041496 -
Prevention Of Recurrence Of Atrial Fibrillation
|
Phase 2 | |
| Not yet recruiting |
NCT06200311 -
Atrial Fibrillation (AF) Ablation to Prevent Disease Progression of AF-induced Atrial Cardiomyopathy in Women and Men
|
N/A | |
| Completed |
NCT04537507 -
Atrial Fibrillation and Non-obstructive Coronary Lesions
|
||
| Completed |
NCT04761315 -
Detecting Atrial Fibrillation in Patients With an Embolic Stroke of Undetermined Source (From the DAF-ESUS Registry)
|
||
| Completed |
NCT00911300 -
Evaluation of Fondaparinux in Patients With a Heart Rhythm Disturbance Who Undergo Restoration of Normal Heart Rhythm
|
Phase 2 |